ONB
XBI icon

Old National Bancorp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Old National Bancorp’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$897K Sell
5,669
-299
-5% -$40.4K 0.02% 301
2026
Q1 		$762K Sell
5,968
-56,104
-90% -$7M 0.01% 336
2025
Q4 		$7.57M Buy
62,072
+386
+0.6% +$44.3K 0.13% 137
2025
Q3 		$6.18M Sell
61,686
-69
-0.1% -$6.21K 0.11% 161
2025
Q2 		$5.12M Buy
61,755
+56,471
+1,069% +$4.51M 0.09% 175
2025
Q1 		$429K Buy
5,284
+285
+6% +$25.5K 0.01% 355
2024
Q4 		$450K Buy
+4,999
New +$484K 0.01% 399

Other funds holding XBI

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Old National Bancorp's XBI Position: Q2 2026 in Review

Old National Bancorp reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 5% in Q2 2026, selling an estimated $40.4K and leaving 5,669 shares worth $897K. The position accounts for 0.02% of the portfolio, ranked #301.

Old National Bancorp first reported a position in XBI in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.57M in Q4 2025. 260 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Old National Bancorp held 5,669 shares of State Street SPDR S&P Biotech ETF worth $897K as of Q2 2026.
  • Old National Bancorp sold 299 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $40.4K.
  • State Street SPDR S&P Biotech ETF made up 0.02% of Old National Bancorp's portfolio in Q2 2026, its #301 holding.
  • Old National Bancorp first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 7 quarters since.
  • Old National Bancorp's State Street SPDR S&P Biotech ETF position peaked at $7.57M in Q4 2025.
  • 260 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Old National Bancorp's 13F filing for Q2 2026, filed 15 Jul 2026.